The PCHRD is a partnership-based organization, hence, partnership plays a crucial role in making all the endeavours of the Council a success. National, regional, international partnerships leaped from and were made stronger during Forum 2015. The Forum provided a good opportunity to forge alliances to leverage resources to tackle local and global health challenges.
The Council is the official host of the ASEAN Network for Drugs, Diagnostics, Vaccines, and Traditional Medicines Innovation (ASEAN-NDI), the regional network approved by the Association of Southeast Asian Nations as the first health R& D innovation network under its umbrella. Activities towards the establishment of a regional health innovation network in the ASEAN were initiated to enhance progress in product discovery and development in the region through intraregional collaboration and, to contribute to the implementation of the Global Strategy and Plan of Action (GSPA) on Public Health, Innovation and Intellectual Property approved through the World Health Resolution (WHA61.21).
UK Government – Newton Agham
PCHRD now has ties with the UK Government with the Newton Fund Program partnership, a research collaboration between and among Philippine and UK researchers. UK - Medical Research Council (MRC) and PCHRD approved six research collaborations on surveillance, diagnostics, and characterization of infectious diseases such as malaria, HIV, schistosomiasis, dengue, antimicrobial resistance, and tuberculosis.
|ENSURE: Enhanced surveillance for control and elimination of malaria in the Philippines||Research Institute for Tropical Medicine and London School of Hygiene and Tropical Medicine|
|See and Sequence’ - Genomic surveillance of antimicrobial resistant and high-risk pathogenic clones within the Philippines||
Research Institute for Tropical Medicine and Wellcome Trust Sanger Institute
|Triple-D Targets: The UK-Philippines Dengue Diagnostic and Drug Targets Research Consortium||
National Institutes of Health University of the Philippines
|HIV G.E.T (Gaming, Engaging and Testing) Project||
University of the Philippines Manila
|Impact assessment of diagnostic tools for multi-drug resistant (MDR-TB) and drug sensitive tuberculosis (TB) in the Philippines||
De La Salle Health Sciences
|Structure Elucidation and Characterization of the Venus Kinase Receptors of a Philippine Isolate of Schistosoma japonicum||
University of the Philippines Diliman and
DOST and Institut Pasteur partnership is underway for the establishment of Institut Pasteur (IP) Philippines. With the establishment of IP Philippines as the 34th institute, a vast number of opportunities will be unlocked for Filipino researchers as well as for the country’s health system. This partnership would enable the country’s research environment to be more responsive towards public health needs particularly for both emerging and re-emerging infectious diseases.